I obtained a degree in clinical psychology at the University of Cordoba (Argentina), a PhD in social psychology and behavioural sciences methodology in Spain, and completed post-doctoral studies at the Andalusian School of Public Health. There, I conducted research on substance use and public health, and was part of a clinical trial testing pharmaceutical-grade heroin for opioid use disorder. I moved to Canada in 2006 to join Dr. Schechter’s research program and became an Investigator on the NAOMI study, North America’s first heroin-assisted treatment trial. I have led the SALOME study, testing injectable hydromorphone for opioid use disorder, and provided evidence to expand injectable opioid agonist treatment across Canada.

My main research area is public health and substance use, with a focus on innovative treatments for opioid use disorder for people that are not reached by the health care system by optimizing the uptake and effectiveness of these treatments using a person-center approach.

Most of our publications are listed in PubMed and ResearchGate: www.ncbi.nlm.nih.gov/pubmed/?term=oviedo-joekes, www.researchgate.net/profile/Eugenia_Oviedo-Joekes

I am a recipient of 2016 Providence Health Care Research and Mission Award and 2016 Faculty of Medicine Distinguished Achievement Awards: Excellence in Clinical or Applied Research.

Providence Health Care Meet and Greet page: http://phcnews.ca/news/dr-eugenia-oviedo-joekes-lead-researcher-salome

 

My office at St. Paul’s Hospital: 588 – 1081 Burrard Street, Vancouver, BC, V6Z 1Y6
My office at SPPH: 269 – 2206 East Mall, Vancouver, BC, Canada V6T 1Z3
SPPH 550 Public Health Approaches to Addictions
SPPH 507/607 MSc/PhD Research Seminar